AI-Powered Oncology Specialist Iambic Therapeutics Targets $135m Nasdaq IPO Amid Bumper Year for Biotech
NEW YORK — Iambic Therapeutics, an oncology-focused biotechnology company backed by high-profile venture capital and…
Tag: biotech
Bridging the Biotech Valley of Death: Europe’s New Open Innovation Platform Opens Its Doors in Clermont-Ferrand
CLERMONT-FERRAND, France — Exactly two years after its ambitious inception, the Biotech Open Platform has…
